Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting

Irene Appolloni(University of Genoa), Paolo Malatesta(Ospedale Policlinico San Martino), Fabrizio Loiacono(Ospedale Policlinico San Martino), Daniela Marubbi(Ospedale Policlinico San Martino), Francesco Alessandrini(University of Genoa), Daniele Reverberi(Ospedale Policlinico San Martino), Davide Ceresa(University of Genoa), Eleonora Gambini(University of Genoa)
Cancer Letters
October 9, 2018
10.1016/j.canlet.2018.10.006
Cited by 21

Related Papers

Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and extracellular vesicles (EVs)
|Biomaterials|2020|136
Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model
|Oncogene|2019|78
Early clonal extinction in glioblastoma progression revealed by genetic barcoding
|Cancer Cell|2023|32
Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity
|Neuro-Oncology|2023|24
Comprehensive Profiling of Secretome Formulations from Fetal- and Perinatal Human Amniotic Fluid Stem Cells
|International Journal of Molecular Sciences|2021|21